This resolution designates May 2025 as ALS Awareness Month to recognize the severity of Amyotrophic Lateral Sclerosis and support patients, caregivers, and research efforts.
Lisa Murkowski
Senator
AK
This resolution officially designates May 2025 as ALS Awareness Month to highlight the serious and progressive nature of Amyotrophic Lateral Sclerosis. It recognizes the challenges faced by the tens of thousands affected, including long diagnosis times and the burden on caregivers. The Senate commits to supporting research, improving access to treatment and support services, and honoring those working to combat the disease.
This resolution officially designates May 2025 as "ALS Awareness Month," shining a spotlight on Amyotrophic Lateral Sclerosis, often known as Lou Gehrig's disease. While resolutions don't change laws or hand out funding, they serve as a powerful statement of priorities, and this one clearly positions the Senate behind efforts to combat ALS and support those affected.
This resolution doesn't mince words about the brutal nature of ALS. It highlights that the average life expectancy after diagnosis is tragically short—only two to five years. For busy folks juggling work and family, the resolution points out a critical issue: it often takes over a year to get a definitive diagnosis after symptoms first appear, precious time lost when treatment could begin. The disease progressively strips people of their ability to move, speak, swallow, and eventually breathe, making it a constant, high-stakes battle for patients and their families.
The resolution specifically recognizes the enormous burden placed on spouses, children, and family members who become full-time caregivers. This isn't just an emotional toll; it’s a financial one. As the disease advances, the need for specialized medical equipment and home care services leads to significant out-of-pocket costs, especially since there is currently no cure. By formally acknowledging the caregiver's struggle, the Senate is signaling that this group deserves more attention and support.
One key detail is the recognition that military veterans are diagnosed with ALS at a higher rate than the general population. This highlights an ongoing health disparity that the government needs to address. Furthermore, the Senate commits to several goals, including ensuring effective treatments are accessible, researching causes and risk factors, and empowering people with ALS to maintain their independence for as long as possible. These are aspirational goals, but they set a clear focus for future legislative and funding efforts, aiming to improve the quality and length of life for those currently battling the disease.